Additionally, Kyvsgaard et al. were able to detect pretreatment genomic alterations in 56 patients with B-NHL who received CD20 × CD3 BsAbs between 2017 and 2023 by performing Next Generation Sequencing (NGS) with a custom lymphoma panel [15]. Here, MS4A1 is linked to lymphoma.